tirzepatide is the same as zepbound (tirzepatide) superior to Wegovy (semaglutide), says Lilly-funded clinical trial Zepbound vs Mounjaro: Same Drug,

Medical disclaimer The assessment offered by Alternate Health Club does not create a doctor-patient relationship

Some providers are prescribing it even though it is not yet FDA-approved and probably wont be FDA Approved until 2027

Of note, the patient was not using other medications for hair growth

Ethics Approval Not applicable

doi:10.3803/EnM.2024.1942 Lilly Investor Relations, News Release: Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine, May 11, 2025

Currently, federal law bans Medicare from covering the drugs when used for weight loss, though they usually are covered when used to treat diabetes and cardiovascular disease